EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters

Li Zhan iD, Jon Edd, Avanish Mishra, Mehmet Toner iD

Advanced Science · 2024

DOI: 10.1002/advs.202405853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Li Zhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, 02129, USA. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Screening liters of blood (i.e., apheresis) represents a generalized approach to promote the reliable access to circulating tumor cell clusters (CTCCs), which are known to be highly metastasis‐competent, yet ultrarare. However, no existing CTCC sorting technology has demonstrated high throughput, high yield, low shear stress, and minimal blood dilution simultaneously as required in apheresis. Here, a label‐free method is introduced termed Precision Apheresis for Non‐invasive Debulking of cell Aggregates (PANDA) to continuously isolate CTCCs from undiluted blood to clean buffer through size sorting, processing 1.4 billion cells per second. The cell focusing is optimized within whole blood leveraging secondary transverse flow and margination. The PANDA chip recovers >90% of spiked ≈24 rare HeLa cell clusters from 100 mL undiluted blood samples (equivalent to ≈500 billion blood cells) at 1 L h −1 throughput, with ≤20s device residence time, ≤15 Pa shear stress, and >99.9% return of blood components. The technology lays the groundwork for future routine isolation to increase the recovery of these ultrarare yet clinically significant tumor cell populations from large volumes of blood to advance cancer research, early detection, and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingHumansBlood Component RemovalCell SeparationHeLa CellsMicrofluidics

Stichwörter der Autor:innen

apheresiscirculating tumor cell clusterslabel‐free sortingmicrofluidic

Autor:innen und Institutionen

  • Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, 02129, USA.
  • Harvard Medical School, Boston, MA, 02115, USA.
  • Cancer Center, Massachusetts General Hospital, Boston, MA, 12129, USA.
  • Shriners Hospitals for Children, Boston, MA, 02114, USA.

ORCID-Profile: Li Zhan, Mehmet Toner

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Zhan, L., Edd, J., Mishra, A., & Toner, M. (2024). Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters. Advanced Science. https://doi.org/10.1002/advs.202405853

Vancouver

Zhan L, Edd J, Mishra A, Toner M. Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters. Advanced Science. 2024. doi:10.1002/advs.202405853

BibTeX
@article{Zhan2024,
  author = {Zhan, Li and Edd, Jon and Mishra, Avanish and Toner, Mehmet},
  title = {Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202405853}
}
Kostenlos starten →